Skip to main content
OpenTrials

Clinical trial condition

Herpesviridae Infections

Explore clinical trials studying Herpesviridae Infections. Study availability and eligibility vary by location and protocol.

1,822 public trials 252 recruiting studies
Refine in advanced search Browse all conditions

Herpesviridae Infections trial results

Recruiting

A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of Age

NCT06855160

Conditions
Chickenpox, DNA Virus Infections, Herpesviridae Infections, +3 more
Locations
  • GSK Investigational Site Tucson, Arizona, United States
  • GSK Investigational Site Huntington Park, California, United States
  • GSK Investigational Site Sherman Oaks, California, United States
  • GSK Investigational Site Coral Gables, Florida, United States
View all 22 locations
View Trial Details
Recruiting

A Study on the Immune Response and Safety of the Second Dose of an Investigational Chickenpox Vaccine When Given to Healthy Children 3 Months After a First Dose at 12 to 15 Months of Age

NCT06806137

Conditions
Chickenpox, DNA Virus Infections, Herpesviridae Infections, +3 more
Locations
  • GSK Investigational Site Salvaleón de Higüey, La Altagracia Province, Dominican Republic
  • GSK Investigational Site Constanza, Dominican Republic
  • GSK Investigational Site Santo Domingo Oeste, Dominican Republic
  • GSK Investigational Site San Pedro Sula, Honduras
View Trial Details
Recruiting

AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia

NCT06137118

Conditions
B-cell Acute Lymphoblastic Leukemia (B-ALL), Burkitt Lymphoma, DNA Virus Infections, +17 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Duarte, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site Palo Alto, California, United States
View all 80 locations
View Trial Details
Recruiting

A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy

NCT03394365

Conditions
Allogeneic Hematopoietic Cell Transplant, DNA Virus Infections, Epstein-Barr Virus Infections, +12 more
Locations
  • City of Hope (Adults and Pediatrics) Duarte, California, United States
  • University of California San Diego Moores Cancer Center (Adults only) La Jolla, California, United States
  • Loma Linda University Medical Center (Adults only) Loma Linda, California, United States
  • Children's Hospital Los Angeles, Div. of Research Immunology/BMT (Adults and Pediatrics) Los Angeles, California, United States
View all 71 locations
View Trial Details
Recruiting

Study Evaluating the Efficacy and Safety of Artesunate

NCT06853184

Conditions
CMV Infection, Cytomegalovirus Infections, DNA Virus Infections, +3 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Westmead Hospital Westmead, Australia
  • Princess Alexandra Hospital Woolloongabba, Australia
View Trial Details
Recruiting

Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant

NCT03779854

Conditions
Acute Biphenotypic Leukemia, Acute Leukemia, Acute Leukemia of Ambiguous Lineage, +54 more
Locations
  • Children's Hospital of Los Angeles Los Angeles, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Children's Healthcare of Atlanta Atlanta, Georgia, United States
  • University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States
View Trial Details

Related conditions